Skip to main content

Rocket Pharmaceuticals, Inc.

RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001281895

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q1 2025 vs. Q4 2024

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of RCKT: Q4 2024 compared with Q1 2025
MeasureQ4 2024Of which not filed for Q1 2025Q1 2025Change
Holders2253236+14
Shares109.6M167.9K107.8M−1.67M (−1.5%)
Value$1.38B$2.11M$722.5M−$653.0M (−47.5%)

3 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to RCKT in Q1 2025
InstitutionSharesValue% of portfolio
Nantahala Capital Management, LLC629,749$4.20M0.35%
MYDA Advisors LLC460,381$3.07M1.09%
Federated Hermes, Inc.414,497$2.76M0.01%
Balyasny Asset Management LLC352,957$2.35M0.01%
Jump Financial, LLC253,723$1.69M0.03%
Susquehanna Fundamental Investments, LLC205,378$1.37M0.02%
Qube Research & Technologies Ltd195,793$1.31M0.00%
Nuveen, LLC178,293$1.19M0.00%
Squarepoint Ops LLC53,476$356.7K0.00%
Axq Capital, LP49,546$330.5K0.13%
Norges Bank44,294$295.4K0.00%
Trexquant Investment LP37,613$250.9K0.00%
Twinbeech Capital LP36,649$244.4K0.00%
Susquehanna Portfolio Strategies, LLC32,096$214.1K0.09%
Capula Management Ltd31,654$211.1K0.00%
Dynamic Technology Lab Private Ltd28,370$189.0K0.03%
Bridgefront Capital, LLC25,709$171.5K0.05%
Entropy Technologies, LP24,612$164.2K0.02%
Gsa Capital Partners LLP24,632$164.0K0.01%
Ieq Capital, LLC24,275$161.9K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH21,406$142.8K0.00%
Engineers Gate Manager LP21,027$140.3K0.00%
Fox Run Management, L.L.C.18,047$120.4K0.02%
Virginia Retirement Systems Et Al17,400$116.1K0.00%
CIBC World Markets Corp17,102$114.1K0.00%
Intrust Bank NA15,811$105.5K0.01%
Aster Capital Management (DIFC) Ltd10,259$96.9K0.02%
Ethic Inc.16,474$95.7K0.00%
PFG Investments, LLC13,400$89.4K0.01%
Virtus Investment Advisers, Inc.13,058$87.1K0.02%
Dark Forest Capital Management LP13,019$86.8K0.00%
Magnetar Financial LLC12,877$85.9K0.00%
Powell Investment Advisors, LLC12,500$83.4K0.04%
Ameriprise Financial Inc12,384$82.6K0.00%
Oxford Asset Management LLP12,309$82.1K0.04%
LJI Wealth Management, LLC12,000$80.0K0.02%
Schonfeld Strategic Advisors LLC11,432$76.3K0.00%
Graham Capital Management, L.P.11,150$74.4K0.00%
HSBC Holdings PLC10,583$69.1K0.00%
Coldstream Capital Management Inc1,710$11.4K0.00%
Group One Trading, L.P.1,084$7.23K0.00%
GWM Advisors LLC600$4.00K0.00%
NBC Securities, Inc.437$2.00K0.00%
Boston Private Wealth LLC242$1.61K0.00%
Parkside Financial Bank & Trust110$7310.00%
Rialto Wealth Management, LLC91$6070.00%
Stephens Consulting, LLC50$3340.00%
Hughes Financial Services, LLC54$3140.00%
South State Corp.40$2670.00%

Sold out (35)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.

Not filed for Q1 2025 yet (3)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q4 2024 that haven't filed for Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
Nuveen Asset Management, LLC167,716$2.11M
Global Retirement Partners, LLC90$1.13K
Cassady Schiller Wealth Management, LLC62$779